BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23798459)

  • 1. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Lv J; Ehteshami P; Sarnak MJ; Tighiouart H; Jun M; Ninomiya T; Foote C; Rodgers A; Zhang H; Wang H; Strippoli GF; Perkovic V
    CMAJ; 2013 Aug; 185(11):949-57. PubMed ID: 23798459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive blood-pressure control in hypertensive chronic kidney disease.
    Appel LJ; Wright JT; Greene T; Agodoa LY; Astor BC; Bakris GL; Cleveland WH; Charleston J; Contreras G; Faulkner ML; Gabbai FB; Gassman JJ; Hebert LA; Jamerson KA; Kopple JD; Kusek JW; Lash JP; Lea JP; Lewis JB; Lipkowitz MS; Massry SG; Miller ER; Norris K; Phillips RA; Pogue VA; Randall OS; Rostand SG; Smogorzewski MJ; Toto RD; Wang X;
    N Engl J Med; 2010 Sep; 363(10):918-29. PubMed ID: 20818902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Rocco MV; Sink KM; Lovato LC; Wolfgram DF; Wiegmann TB; Wall BM; Umanath K; Rahbari-Oskoui F; Porter AC; Pisoni R; Lewis CE; Lewis JB; Lash JP; Katz LA; Hawfield AT; Haley WE; Freedman BI; Dwyer JP; Drawz PE; Dobre M; Cheung AK; Campbell RC; Bhatt U; Beddhu S; Kimmel PL; Reboussin DM; Chertow GM;
    Am J Kidney Dis; 2018 Mar; 71(3):352-361. PubMed ID: 29162340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
    Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
    Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.
    Ku E; Ix JH; Jamerson K; Tangri N; Lin F; Gassman J; Smogorzewski M; Sarnak MJ
    J Am Soc Nephrol; 2018 Sep; 29(9):2401-2408. PubMed ID: 30006417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Intensive Blood Pressure Target and Cardiovascular Outcomes in the Population With Chronic Kidney Disease: A Retrospective Study in Korea.
    Yoon SY; Kong JY; Jeong SJ; Kim JS; Hwang HS; Jeong K
    J Am Heart Assoc; 2024 Mar; 13(6):e032186. PubMed ID: 38471824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis.
    Inker LA; Levey AS; Pandya K; Stoycheff N; Okparavero A; Greene T;
    Am J Kidney Dis; 2014 Jul; 64(1):74-85. PubMed ID: 24787763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?
    Glasser SP; Basile JN; Lackland DT
    Hypertension; 2009 Nov; 54(5):954-5. PubMed ID: 19720951
    [No Abstract]   [Full Text] [Related]  

  • 9. SPRINT-A Kidney-Centric Narrative Review: Recent Advances in Hypertension.
    Hu AH; Chang TI
    Hypertension; 2021 Sep; 78(4):946-954. PubMed ID: 34365808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: a systematic review and meta-analysis of randomized controlled trials.
    Soliman Y; Nazir A; Abuelazm M; Seri A; Mahmoud A; Abdelazeem B
    Proc (Bayl Univ Med Cent); 2024; 37(4):700-704. PubMed ID: 38910799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in hypertension: new trials, targets and ways of measuring blood pressure.
    Abu Salman L; Cohen JB
    Curr Opin Nephrol Hypertens; 2022 May; 31(3):258-264. PubMed ID: 35249970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks and benefits of intensive blood pressure lowering in patients with type 2 diabetes.
    Rabi DM; Padwal R; Tobe SW; Gilbert RE; Leiter LA; Quinn RR; Khan N; ;
    CMAJ; 2013 Aug; 185(11):963-7. PubMed ID: 23734033
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
    ; Wright JT; Williamson JD; Whelton PK; Snyder JK; Sink KM; Rocco MV; Reboussin DM; Rahman M; Oparil S; Lewis CE; Kimmel PL; Johnson KC; Goff DC; Fine LJ; Cutler JA; Cushman WC; Cheung AK; Ambrosius WT
    N Engl J Med; 2015 Nov; 373(22):2103-16. PubMed ID: 26551272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
    ; Ninomiya T; Perkovic V; Turnbull F; Neal B; Barzi F; Cass A; Baigent C; Chalmers J; Li N; Woodward M; MacMahon S
    BMJ; 2013 Oct; 347():f5680. PubMed ID: 24092942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
    Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
    JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
    Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A
    JAMA; 2015 Feb; 313(6):603-15. PubMed ID: 25668264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Apr; 34(4):613-22. PubMed ID: 26848994
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.